Supplementary Figure 3 from Alternate Splicing of the p53 Inhibitor HDMX Offers a Superior Prognostic Biomarker than p53 Mutation in Human Cancer

Autor: Aart G. Jochemsen, Gareth L. Bond, Anne-Marie Cleton-Jansen, Helge Taubert, Peter Wuerl, Pancras C.W. Hogendoorn, Frank Bartel, Lukasz F. Grochola, Emmanouela Repapi, Amina F.A.S. Teunisse, Marieke L. Kuijjer, Kirsten Lodder, Anna M. Grawenda, Kristiaan Lenos
Rok vydání: 2023
DOI: 10.1158/0008-5472.22391741.v1
Popis: PDF file - 51K, High HDMX-S/HDMX-FL ratios, but not p53 gene mutation associates with worse outcome in soft tissue sarcoma patients
Databáze: OpenAIRE